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Abstract
Background: Stent implantation is the treatment of choice for adolescents and adults with aortic
coarctation (CoAo). Despite excellent short-term results, 20%–40% of the patients develop arterial
hypertension later in life, which was attributed to inappropriate response of the aortic barorecep-
tors to increased stiﬀness of the ascending aorta (ASAO), either congenital or induced by CoAo
repair. In particular, it has been hypothesized that stent itself may cause or sustain hypertension.
Therefore, we aimed to study the hemodynamic and structural impact following stent implantation
in the normal aorta of a growing animal.
Methods: Eight female sheep completed the study and a stent was implanted in four. Every 3 mo
we measured blood pressure of the anterior and posterior limbs and left ventricular function by
echocardiography. Twelve months later invasive pressure was measured under baseline and simu-
lated stress conditions. Expression of genes indicating oxidative stress (OS), endothelial
dysfunction (ED) and stiﬀness, as well as pathological examination were performed in ascending
(ASAO) and descending aorta (DSAO).
Results: SOD1 and MMP9 gene expression were higher in ASAO of the stented animals, com-
pared to DSAO and controls, while NOS3 was decreased. No diﬀerences were found in blood
pressure and echocardiographic parameters. No histological diﬀerences were found in the aorta of
the two groups of animals.
Conclusions: Stent does not aﬀect central and peripheral hemodynamics, cardiac structure and
function even in the long term. However, the ﬁnding of markers of OS and increased stiﬀness of
ASAO, proximal to the stent, points to molecular mechanisms for increased cardiovascular risk of
patients with stented CoAo.
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1 | INTRODUCTION
Aortic coarctation (CoAo) accounts for 5%-7% of all congenital heart
disease1 and it is the sixth most common cardiovascular malformation,
with an incidence of 1:3000 live births.2
Life expectancy of these patients is reduced despite CoAo repair
because of late complications, such as recoarctation, late aneurysm for-
mation, aortic dissection and rupture, premature coronary and cerebro-
vascular disease, many of which can be accounted for by arterial
hypertension.
Even after a complete neonatal correction, patients with CoAo
show increased stiﬀness of the ascending aorta (ASAO) compared to
the descending aorta (DSAO).3–8 The increase of stiﬀness, which ﬁnds
a histological explanation in the increased amount of collagen and
reduced content of elastic ﬁbers and of smooth muscle cells (SMC) in
ASAO,9 has a linear correlation with severity of hypertension.10
CoAo repair by stent implantation has become the treatment of
choice for adolescents and adults,11 but concerns have been raised
regarding the possible negative impact of the stent itself on the aortic
compliance becoming responsible for worsening of hypertension.12–16
The alterations of the laminar ﬂow at the level of the interface
between the native aorta and the stent13 and the consequent induc-
tion of oxidative stress (OS) could in fact worsen hypertension by alter-
ing aortic distensibility.17
The study of the impact of a stent on the aortic wall in patients
born with CoAo is challenging since these patients show a congenitally
altered aortic wall compliance since birth.3–8 Therefore, we designed a
longitudinal proof of concept study to assess the impact of stenting on
central and peripheral hemodynamics, cardiac and aortic structure and
function by implanting a stent in the normal aorta of a growing sheep
and following it up to adult age.
2 | METHODS
2.1 | Animals
For the study we employed twelve female Bergamasca breed sheep
between 3 to 5 mo of age, provided by a sheep farm (Magonara Mauri-
zio, Villa Estense, Padua, Italy).
All animal experiments were conformed to the guidelines from
Directive 2010/63/EU of the European Parliament on the protection
of animals used for scientiﬁc purposes and the study project was com-
municated to the Italian Ministry of Health (project registration number
90/08 C21).
2.2 | Study protocol
The animals were randomly assigned to the Stent (STENT) or Sham
group (SHAM) in a 2:1 ratio.
The study lasted 12 mo. Every 3 mo we measured invasive blood
pressure (BP) of the auricular artery, noninvasive pressure of the ante-
rior and posterior limbs and left ventricular function by echocardiogra-
phy. Invasive pressure was also measured under baseline and simulated
stress conditions at the end of follow-up before sacriﬁce.
2.3 | Anesthesia protocol
Two diﬀerent anesthesia protocols were employed. General anesthesia
with oro-tracheal intubation and mechanical ventilation was adopted
for invasive studies. Unconscious sedation was employed for periodic
echocardiographic follow-up.
The general anesthesia protocol was the following: premedication
with midazolam 0.3 mg/kg and methadone 0.2 mg/kg, induction with
propofol 4-6 mg/kg (dose eﬀect), maintenance with inhalation of Iso-
ﬂurane (dose eﬀect).
Periodic sedation protocol was: premedication with midazolam
0.2 mg/kg, and maintenance of sedation with Propofol 0.5 mg/kg fol-
lowed by constant infusion at 0.1 mg/kg/min.
2.4 | Cardiac catheterization
Two diﬀerent catheterization protocols were employed:
2.4.1 | First catheterization
Under general anesthesia, the animal was positioned in right lateral
recumbence. After surgical scrub of the neck, arterial access was
obtained by surgical exposure of the right common carotid artery and
by modiﬁed Seldinger technique placing a 12 French introducer (fr)
into the artery (Check-Flo Performer Introducer 12 fr, Cook Medical).
Once arterial access was achieved under ﬂuoroscopic guidance
(Radius System S9, Multi Image, Italy), a 5 fr Gensini Catheter (Balt
Extrusion, Montmorency, France) connected to a multiparameter moni-
toring system (Cardiocap II, Dathex-Ohmeda – GE Healthcare) by a
pressure transducer (TruWave Disposal Pressure Transducer, Edward
Lifescience, Switzerland) was employed to collect invasive pressure
data in the left ventricle, ASAO and DSAO.
Once baseline pressure data were recorded, aortogram was per-
formed. At this time, in the animals randomized to the stent group
(STENT), a 39 mm long CP Stent (NuMed Inc, Cornwall, Canada)
mounted over a 23 mm balloon angioplasty catheter (Crystal Balloon
23x40 mm, Balt Extrusion, Montmorency, France) was implanted in the
DSAO distally to the take-oﬀ of the left subclavian artery. To avoid the
stented region to become obstructive during the animal growth we
intentionally dilate the stent to the diameter of DSAO of an adult
sheep. A second contrast injection was performed to evaluate the cor-
rect stent position. In the stent group a new subset of invasive pres-
sure data was obtained before ending the procedure.
At the end of the procedure, the 12 fr introducer was removed,
the right common carotid artery surgically reconstructed, and the ani-
mal awakened.
2.4.2 | Second catheterization
Under general anesthesia, in right lateral recumbence, arterial access was
gained by percutaneous puncture of the right common femoral artery
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with a modiﬁed Seldinger technique placing an 8 fr introducer into the
arterial lumen (Check-Flo Performed Introducer 8 fr, CookMedical).
As previously described, ﬁrstly invasive data were obtained under
baseline conditions in both groups of animals. A simulated exercise
stress test was then performed by continuous iv infusion of Dobut-
amine titrated up to the maximum dose of 10 mcg/kg/min with incre-
mental steps of 2,5 mcg/kg/min. For each step of the stress test, when
the steady state was achieved, invasive pressure recording was
obtained in the left ventricle, ASAO and DSAO.
2.5 | Animal sacriﬁce
At the end of the second catheterization the animals, still under general
anesthesia, were sacriﬁced by administering intravenously a solution of
embutramide, mebenzonium iodide and tetracaine hydrochloride
(Tanax, Intervet, Milan, Italy).
2.6 | Blood pressure measurement
BP was measured invasively and noninvasively every 90 days in both
STENT and SHAM animals. To obtain awake invasive BP measurement,
a catheter in the auricular artery on the abaural surface of the ear was
connected to a monitor (Cardiocap II, Dathex-Ohmeda, GE Healthcare).
Care was taken in handling the animal to reduce stress conditions. All
animals were allowed to remain quietly in the measurement room for 5-
10 min before attempting BP measurement to minimize white coat
eﬀect that could alter pressure values. Noninvasive BP measurement
was monitored under unconscious sedation: an inﬂatable cuﬀ (Critikon,
GE Healthcare) was employed to obtain noninvasive oscillometric limb
pulse pressure (Dathex-Ohmeda, GE Healthcare). The cuﬀ was placed to
the anterior and posterior limbs at the same height of the heart.
2.7 | Echocardiography
In both groups of animals, every 90 days a transthoracic echocardio-
graphic evaluation of the left ventricle was obtained. After sedation the
animal was positioned in the right lateral recumbence. The echocardio-
graphic examination was performed according to the previously
described protocol.56
2.8 | Blood tests
Every 90 days blood samples were obtained for determination of com-
plete blood count with diﬀerentials, and plasma total proteins, albumin,
globulin, BUN, creatinine, bilirubin, AST, ALT, GGT, LDH, CK, ALP, Ca,
P, Mg, Na, K, Cl, glucose.
2.9 | Histological analysis
After sacriﬁce, from each animal the aorta was harvested for histologi-
cal analysis.
After formalin ﬁxation, the aorta was opened longitudinally and digi-
tal images were acquired. For histopathological analysis, 3 tissue samples
were cut from each aorta: a sample 1 cm proximal and distal to the stent
and one sample from the area in which the stent was inserted. Aortas
from untreated control animals were sampled at corresponding levels.
After sampling, the aortic tissue was immediately embedded in
paraﬃn and subsequently cut and stained in hematoxylin-eosin (H&E)
and elastic Weigert van Gieson. Medial thickness was quantiﬁed by
obtaining digital images with a light microscope (Zeiss Axioplan2IE and
Zeiss AxioCam MRc cameras; Carl Zeiss MicroImaging GmbH, Jena,
Germany) and measuring the distance between the internal and exter-
nal elastic laminas in elastic Weigert van Gieson–stained segments.
The mean thickness value was determined. Intimal proliferation at the
level of stent implantation was also assessed.
2.10 | Gene expression
For a detailed description of the methods relative to aortic gene
expression refer to Supporting Information methods (Appendix S1).
Specimens from DSAO and ASAO, respectively 1 cm proximal and dis-
tal to the stent, were isolated and preserved in RNAlater solution (Qia-
gen, Hilden, Germany). After removal of RNAlater, the tissue sample
was immersed in liquid nitrogen and conserved at 2808C until use.
After RNA extraction, the expression of the following genes, markers
TABLE 1 Somatic growth
SHAM (n54) STENT (n54) p
Day 0 30.662.1 29.362.1 ns
Day 90 38.562.8 37.964.8 ns
Day 180 48.263.9 48.764.6 ns
Day 270 56.065 59.563.4 ns
Day 360 57.864.7 62.264.1 ns
Values are expressed in kg and as mean6 standard deviation (ns: no sta-
tistical signiﬁcance). n is the number of animals in each group.
TABLE 2 Direct auricular blood pressure in awake SHAM and STENT sheep at baseline and follow up
Systolic blood pressure Diastolic blood pressure Pulse pressure
SHAM
(n54)
STENT
(n54)
SHAM
(n54)
STENT
(n54)
SHAM
(n54)
STENT
(n54) P value
Day 0 1076 10 1216 8 74611 9667 33610 2562 ns
Day 90 1126 10 1026 11 7664 73614 3568 29611 ns
Day 180 1196 8 1196 8 8567 76610 34610 4366 ns
Day 270 1116 12 1156 15 8067 8269 3168 31611 ns
Day 360 1086 14 1126 8 7569 8266 3466 3065 ns
Values are expressed in mm Hg as mean6 SD (ns: no statistical signiﬁcance). n is the number of animals in each group.
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of OS, ED, matrix remodeling and stiﬀness were tested by means of
Real-Time PCR: SOD1, NOS3, ICAM-1, E Selectin, Caspase 3, and
MMP9.
Validation of speciﬁcity of qPCR assay was performed by melt-curve
analysis and by agarose gel analysis. b-actin was used as housekeeping
gene. Data analyses were performed with the iQTMOptical System Soft-
ware (Bio-Rad, Hercules, CA). The comparative cycle threshold method
(DDCt), which compares the diﬀerence in cycle threshold values between
groups, was used to obtain the relative fold change of gene expression.
2.11 | Statistical analysis
All data are expressed as mean6 SD. Nonparametric paired and
unpaired tests were used for the statistical analysis. One-way ANOVA
was employed to analyze time dependent diﬀerences. Statistical signiﬁ-
cance was assumed at P< .05. Statistical analysis was performed with
SPSS 15 software package (SPSS, Chicago, IL).
3 | RESULTS
3.1 | Outcome
Between July 2008 and March 2011, 12 animals were enrolled in the
study and a stent was implanted in the aortic isthmus in eight of them.
In the group of stented animals, three died. The ﬁrst one died dur-
ing the procedure because of aortic dissection, two animals died
because of sepsis, 2 and 3 days after the procedure. One animal within
the stent group was excluded from the study because of the develop-
ment of severe aortic regurgitation following bacterial endocarditis.
Four animals in the STENT group and four animals in the SHAM group
completed the 12-mo follow-up and their data were compared.
3.2 | Somatic growth
STENT and SHAM animals showed a similar somatic growth as pre-
sented in Table 1. In particular, at the time of the ﬁrst catheterization
STENT and SHAM animals weighted respectively 29.362.1 and
30.662.1 kg and reached a similar weight at the end of the follow up
weighting respectively 62.264.1 and 57.864.7 kg.
3.3 | Blood pressure
There were no diﬀerences in term of direct auricular, indirect oscillo-
metric and direct aortic pressure neither at the ﬁrst catheterization nor
at the following examinations up to the end of the 12 mo of follow-up
between the two groups of animals.
Tables 2 and 3 report the direct auricular BP in awake SHAM and
STENT sheep and noninvasive limb BP in sedated SHAM and STENT
groups. Table 4 reports the hemodynamic data obtained at the time of
the ﬁrst and second cardiac catheterization.
3.4 | Dobutamine stress test
The results of the dobutamine stress test are depicted in Figures 1 and
2. In both group of animals, heart rate (Figure 1) and BP in the ASAO
and DSAO (Figure 2) did not diﬀer signiﬁcantly.
3.5 | Echocardiography
Supporting Information Table S1 summarizes the echocardiographic
data obtained at the time of the ﬁrst cardiac catheterization and every
90 days. None of the variables showed a statistical diﬀerence during
follow-up in the two groups of animals.
TABLE 3 Noninvasive pressure of anterior and posterior limbs in sedated SHAM and STENT sheep
Systolic blood pressure
anterior limbs
Systolic blood pressure
posterior limbs
Diastolic blood pressure
anterior limbs
Diastolic blood pressure
posterior limbs
SHAM
(n54)
STENT
(n54)
SHAM
(n54)
STENT
(n54)
SHAM
(n54)
STENT
(n54)
SHAM
(n54)
STENT
(n54) P value
Day 90 134612 1226 24 12968 116615 82611 84620 786 8 68615 ns
Day 180 129614 1176 18 11667 117611 84613 7964 666 12 7767 ns
Day 270 121617 1346 4 116611 13462 6864 97621 656 12 8764 ns
Day 360 118612 1256 16 12368 12465 7268 71614 696 10 67616 ns
Values are expressed in mm Hg as mean6 SD (ns: no statistical signiﬁcance). n is the number of animals in each group.
TABLE 4 Invasive pressure in ascending and DSAO at the time of the ﬁrst cardiac catheterization (day 0) before and after stent implantation
and at the time of the second cardiac catheterization (day 360) in SHAM and STENT groups
Systolic pressure
ascending aorta
Systolic pressure
descending aorta
Diastolic pressure
ascending aorta
Diastolic pressure
descending aorta
SHAM
(n54)
STENT
(n54)
SHAM
(n54)
STENT
(n54)
SHAM
(n54)
STENT
(n54)
SHAM
(n54)
STENT
(n54) P value
Prestent day 0 88619 94619 88619 956 18 77623 74621 74618 73619 ns
Poststent day 0 / 100620 / 1016 27 / 78621 / 74626 ns
Day 360 9969 9969 99610 986 8 8368 8468 8369 8268 ns
Values are expressed in mm Hg as mean6 SD (ns: no statistical signiﬁcance). N is the number of animals analyzed in each group.
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3.6 | Blood tests
None of the biochemical parameters was consistently diﬀerent among
groups during time (data not shown).
3.7 | Histological analysis
Histology of the aorta in control animals showed that the aortic wall
consists of 3 layers like in humans. However, the media is composed
by smooth muscle cells (SMC) and layers of elastic and collagen ﬁbers
with a disarrayed spatial arrangement. In STENT, the ﬁndings in the
nonstented aortic segments were the same as in controls, reﬂecting a
species-related feature rather than a stent-related structural change. In
the control aortas, the mean thickness of the tunica media was 2369
650 mm.
Substantial diﬀerences were seen when comparing medial thick-
ness of nonstented segments with stented aortic wall specimens. Sig-
niﬁcant medial thinning was observed in all stent-covered regions. At
this level, the elastic and collagen ﬁbers were stretched. In particular,
the mean aortic wall thickness was 29516570 mm proximal to the
stent, 2496694 distally and 1524680 within the covered aortic seg-
ment (P< .001). No inﬂammatory inﬁltrate was seen either proximal or
distal to the stent.
In all stent-covered regions, the metal struts left indentations in
the aortic wall. Mild neointimal proliferation, partially covering stent
mesh and never determining stenosis of the lumen, was observed in
treated animals. Stent struts were not always uniformly distended
and neointima covering was incomplete in some areas. Despite neo-
intima proliferation, aortic wall thickness at stent level was reduced
in comparison with segments proximal and distal to the device (Fig-
ures 3 and 4).
3.8 | Gene expression
NOS3 expression was signiﬁcantly lower in ASAO of stented animals
compared to ASAO of controls (1.0460.17 vs. 1.3460.36), while
SOD1 expression was higher in ASAO of stented animals (1.4260.39)
compared to ASAO of controls (0.9560.16) and to DSAO of both
stented and controls animals (0.6860.11 and 0.7760.07, respec-
tively). Similarly, MMP9 expression was higher in ASAO of stented ani-
mals (1.6860.45) compared to ASAO of controls (0.9660.07) and to
DSAO of both stented and controls animals (1.0660.25 and
1.2260.46, respectively). The relative fold change of gene expression
of SOD1, NOS3, ICAM-1, E Selectin, Caspase 3, and MMP9 in STENT
is shown in Figure 5 and the relevant data are reported in Supporting
Information Table S2. These data indicate increased focal aortic OS
associated with compensatory SOD1 overexpression, and accelerated
vascular remodeling, that may herald increased wall stiﬀness in ASAO
of stented aortas.
4 | DISCUSSION
Animal models are essential tools for cardiovascular research to under-
stand pathophysiological processes and to develop new therapies.18
Among large animal models, sheep are most suitable because of their
docility, slow growth and easy housing in long-term follow up studies.
Furthermore, the sheep is a good animal model for cardiovascular stud-
ies because its heart is similar in dimensional and functional parameters
to the human heart and its vascular anatomy bears close resemblance
to the human vasculature.19,20 The present study in grown up sheep
shows that aortic stent implantation does not cause hypertension and
cardiovascular remodeling but it increases the expression of markers of
OS, ED and aortic stiﬀness. Thus, this proof of concept study rules out
a direct eﬀect of stent in inducing hypertension in the normal aorta of a
growing animal, but highlights molecular mechanisms that may have a
role in increasing the cardiovascular risk of patients with stented CoAo.
The long-term prognosis of patients after CoAo repair is jeopar-
dized by development or persistence of arterial hypertension, which
aﬀects up to 40% of patients at follow-up.21–26 Its pathogenesis is
poorly understood. Many diﬀerent mechanisms have been involved:
hyperactivity of the renin-angiotensin-aldosterone system,27 impaired
aortic compliance,4,5,15,28 altered sensibility of the baroreceptors,3,29,30
peculiar aortic shape,22 ASAO relative hypoplasia,31 generalized arterial
and aortic dysfunction,4,7,31 and ED,3 that could not be corrected by
either surgical or endovascular repair. It has also been hypothesized
that the turbulent ﬂow across the repaired segment promotes medial
thickening and predisposes these patients to the development of
hypertension by increasing the parietal stress in ASAO, even in the
FIGURE 1 Heart rate at diﬀerent dobutamine doses in stent and
sham sheep. Dobutamine doses are expressed in mcg/kg/min.
Heart rate values are expressed in beats per minute
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absence of signiﬁcant recoarctation.6,32–34 The altered aortic compli-
ance, which is a feature of all the patients with CoAo even before cor-
rection,5,10,29,30 may lead to the development of high BP by impairing
baroreceptor reﬂexes.9,30
Stent implantation is the treatment of choice for adolescents and
adults with CoAo.11 Despite excellent immediate results, few long-
term data are available and no data are available about the possible
long-term negative eﬀects of the stent on the development or mainte-
nance of hypertension. Some authors argued that the stent could fur-
ther reduce aortic compliance by causing loss of pulsatile energy,
increased impedance to blood ﬂow with reduction of distal perfusion,
increased reﬂection of pressure waves and increased mechanical stress
at the interface between stent and native aorta.12–14,16,35 Others dem-
onstrated that ASAO of patients born with CoAo is stiﬀer than ASAO
of the normal population and this is not corrected either by surgery or
stent implantation, but they did not conﬁrm alterations of aortic com-
pliance by stenting.36–38
Our long-term study demonstrates that the stent does not alter
the overall hemodynamics of the aorta in agreement with what it was
reported by Pihkala et al. in a short-term experiment in pigs.39 In fact,
after 12-mo follow-up in full grown up sheep, the aortic pressure
behavior was similar in the two groups of animals both at rest and
under simulated exercise stress and there were no diﬀerences in left
ventricular dimension and function. However, alterations of the normal
laminar blood ﬂow at the level of the interface between the stent and
the native artery induced OS, ED and increased protein turn over in
the ASAO above the stent.
The role of the ED is gaining more and more interest in the patho-
genesis of hypertension. Alteration of endothelium-mediated vasodila-
tation is present in patients with hypertension, dyslipidemia, diabetes
FIGURE 2 Mean systolic pressure in ascending and DSAO at diﬀerent dobutamine doses in stent and sham sheep. In the left panel,
systolic blood pressure in the ASAO, in the right panel, systolic blood pressure in the DSAO. Dobutamine doses are expressed in mcg/kg/
min. Blood pressure values are expressed in mm Hg
FIGURE 3 Formalin-ﬁxed aortic stented segment after section of
the wall. Wall thickness at stent level is reduced from segments
above and below the device
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and coronary artery disease.40–42 Endothelial damage plays a critical
role in restenosis after stenting,43 but nothing is known on endothelial
function in the presence of a stent in the isthmic region. In our experi-
mental model, in stented animals we found decreased expression of
NOS3 and increased gene expression of SOD1 and MMP9 in ASAO.
The decreased NO production by NOS3, the increased OS, suggested
by high compensatory SOD1 expression, and the increased collagen
turnover, expressed by elevated expression of the MMP9 limited to
ASAO proximal to the stent and not in DSAO, underlie ED, possibly
caused by backward reﬂection of the pressure waves determined by
the stent.
The activation of proteolytic and apoptotic processes contrib-
utes to structural changes of the extracellular matrix and SMC
layers of the arterial vessels. MMP family plays a critical role in the
degradation of the proteins of the extracellular matrix and in the
physiologic remodeling of the vessels.44,45 The overexpression of
MMP proteins shown in our experimental model can lead to inap-
propriate vascular remodeling favoring aneurysm formation, reste-
nosis and accelerated arteriosclerosis.44,46–48 MMP9 is, in fact, an
important member of the MMP family and increased levels of this
protein were found in patients with coronary artery disease, type 2
diabetes and early arteriosclerosis.46,48–50 Increased levels of this
protein are associated with increased stiﬀness of the aortic wall and
increased mortality for coronary artery diseases.51,52 Production of
collagen ﬁbers at a faster rate than the elastic ones makes the arte-
rial wall stiﬀer.52 All these structural changes in ASAO may predis-
pose to aneurysm formation and dissection, well-known
complications of CoAo repair.1
The correlation between higher aortic wall stiﬀness and higher
risk of hypertension has been well demonstrated.53 In patients with
FIGURE 4 Histological sections of aortic wall. ASAO in a STENT (A) and a SHAM (B) sheep. Stented aortic segment (C) with mild
neointimal proliferation around the mesh
FIGURE 5 Relative percent change of gene expression in the
ascending (blue bars) and descending (red bars) aorta of STENT.
The data are expressed as percent change of gene expression
in the same aortic segment of SHAM, taken as reference value.
(* P< .05, ** P< .01 vs SHAM)
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a stiﬀ aortic wall there is an improper matching between aortic
diameter and ﬂow that cause an increase in forward arterial pres-
sure wave amplitude, elevated pulse-wave velocity and premature
wave reﬂection. The resulting increase in pulsatile hemodynamic
load increases cardiac afterload, reduces diastolic coronary ﬂow,
and damages microcirculation, particularly in high-ﬂow organs such
as the kidneys and brain.54,55 The changes of SOD1, NOS3, and
MMP9 gene expression, in our long term experiment in the ovine
animal model were not accompanied by anatomically and function-
ally evident cardiac and vascular abnormalities. Our data, therefore,
suggest that the development of hypertension in patients with
repaired CoAo needs a preexisting aortopathy to accelerate the
increase of aortic wall stiﬀness.3–6,28
The main study limitation is the small number of animals employed.
Its strength is the remarkably long follow-up with animals followed up
from infancy to maturity, mimicking the human development from ado-
lescence to adult age.
Having implanted a stent in the aorta of otherwise normal
animals, we conclude the stent induces OS, ED, and increased
stiﬀness in ASAO but not hypertension. Even if we did not ﬁnd
any vascular remodeling of the aorta in this animal model, OS,
ED, and aortic matrix changes following stent implantation is
worrisome. At present we cannot predict what clinical relevance
they may have on the aorta of patients who have a congenital
abnormality of the aortic wall since birth as in CoAo. They may
lead to vascular changes with development of aneurism, a well-
known complication of coarctation repair. Therefore, we suggest
periodic noninvasive examination of the proximal aorta in patient
with stented COAO for early recognition of long term complica-
tions, such as aneurysm formation, even in the absence of hyper-
tension following repair.
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